Top Markets
#1 Pleasing Gold Pleasing Gold +656.39%
#2 Islamic Coin Islamic Coin +154.16%
#3 PulseChain PulseChain +56.20%
#4 BOOK OF MEME BOOK OF MEME +42.24%
#5 DogBull DogBull +37.63%
#6 Neiro Neiro +21.68%
#7 Collect on Fanable Collect on Fanable +21.03%
#8 Nockchain Nockchain +17.26%
#9 PondCoin PondCoin +16.48%
#10 rsERG rsERG +16.48%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Trident Lifeline Limited Trident Lifeline Limited

Trident Lifeline Limited

TLL
Rank in Stocks #26878
Trident Lifeline Limited operates as a manufacturer and distributor of... Trident Lifeline Limited operates as a manufacturer and distributor of pharmaceutical goods. The company actively engages in the ethical marketing of its medicinal portfolio, serving both national and international markets. Its offerings encompass a range of pharmaceutical formulations and other products, which are produced via contract manufacturing arrangements under loan licenses. Founded on January 9, 2014, the firm maintains its headquarters in Surat, India.
Share Price
$3.09
Market Cap
$36.86M
Change (1 day)
-1.22%
Change (1 year)
-3.92%
Country
IN
Trade Trident Lifeline Limited (TLL)

Category

Healthcare
P/E ratio for Trident Lifeline Limited (TLL)
P/E ratio as of 2026 TTM: 0
According to Trident Lifeline Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Trident Lifeline Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 24.32 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.13 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.